Arkadios Wealth Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$691K Sell
9,706
-58
-0.6% -$4.57K 0.01% 956
2025
Q4
$801K Buy
9,764
+402
+4% +$31.3K 0.02% 799
2025
Q3
$703K Sell
9,362
-8,246
-47% -$615K 0.02% 791
2025
Q2
$1.3M Buy
17,608
+5,329
+43% +$371K 0.04% 473
2025
Q1
$991K Buy
+12,279
New +$1.06M 0.04% 462

Other funds holding GEHC

Arkadios Wealth Advisors's GEHC Position: Q1 2026 in Review

Arkadios Wealth Advisors reduced its GE HealthCare (GEHC) stake by 0.59% in Q1 2026, selling an estimated $4.57K and leaving 9,706 shares worth $691K. The position accounts for 0.01% of the portfolio, ranked #956.

Arkadios Wealth Advisors first reported a position in GEHC in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.3M in Q2 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Arkadios Wealth Advisors held 9,706 shares of GE HealthCare worth $691K as of Q1 2026.
  • Arkadios Wealth Advisors sold 58 GE HealthCare shares in Q1 2026, an estimated $4.57K.
  • GE HealthCare made up 0.01% of Arkadios Wealth Advisors's portfolio in Q1 2026, its #956 holding.
  • Arkadios Wealth Advisors first reported a position in GE HealthCare in Q1 2025 and has held it in 5 quarters since.
  • Arkadios Wealth Advisors's GE HealthCare position peaked at $1.3M in Q2 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.